SMALL MOLECULE PREFILLED SYRINGES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Prefilled syringes have several advantages over traditional vial packaging, including ease of use. Prefilled syringes obviate the need for the processes that are required before using a drug in a vial. It also helps to eliminate dosing errors because prefilled syringes contain the exact dose. Many pharmaceutical manufacturers overfill vials by up to 25% to ensure that the end user receives the correct dose. However, overfilling can result in errors that are virtually eliminated with prefilled syringes. With the introduction of more expensive biotech drugs, this is advantageous because it means less waste, particularly if some vaccines are in short supply or extremely expensive.

Market Dynamics

Market players are focused on product launches or approvals, which is expected to contribute to the growth of the global small molecule prefilled syringes market over the forecast period. For instance, in March 2018, Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) 0.3 mg prefilled syringe (PFS) as a new method of administering the medicine to treat all forms of diabetic retinopathy.

Market players are focused on launching manufacturing capabilities for prefilled syringes. This is expected to drive the market growth over the forecast period. For instance, in July 2019, Terumo Corporation, based in Japan, announced the construction of an additional production facility for pre-filled syringes at its subsidiary Terumo Yamaguchi D&D.

Market players focused on product launches is expected to propel the growth of the global small molecule prefilled syringes market. For instance, in March 2020, Dr. Reddy's Laboratories Ltd., a leading multinational pharmaceutical company, announced the launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe, a therapeutic equivalent generic version of Narcan (naloxone hydrochloride) Injection USP in India.

Key features of the study:

• This report provides an in-depth analysis of global small molecule prefilled syringes market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global small molecule prefilled syringes market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Sanofi, Viatris Inc. (Mylan N.V.), AstraZeneca Plc, F. Hoffmann-La Roche AG (Genentech, Inc.), Sun Pharmaceutical Industries Ltd., Pfizer Inc., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, and McKesson Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global small molecule prefilled syringes market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global small molecule prefilled syringes market

Detailed Segmentation:

• Global Small Molecule Prefilled Syringes Market, By Drug Class:
  • Cardiovascular Drugs
  • Neurology Drugs
  • Analgesics
  • Adjuvants
  • Others
• Global Small Molecule Prefilled Syringes Market, By Material Type :
  • Glass
  • Plastic & Polymer
• Global Small Molecule Prefilled Syringes Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Small Molecule Prefilled Syringes Market, By Region:
  • North America
    • By Drug Class:
      • Cardiovascular Drugs
      • Neurology Drugs
      • Analgesics
      • Adjuvants
      • Others
    • By Material Type:
      • Glass
      • Plastic & Polymer
    • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Drug Class:
      • Cardiovascular Drugs
      • Neurology Drugs
      • Analgesics
      • Adjuvants
      • Others
    • By Material Type:
      • Glass
      • Plastic & Polymer
    • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Drug Class:
      • Cardiovascular Drugs
      • Neurology Drugs
      • Analgesics
      • Adjuvants
      • Others
    • By Material Type:
      • Glass
      • Plastic & Polymer
    • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Country:
      • U.K.
      • Germany
      • Italy
      • Spain
      • France
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Drug Class:
      • Cardiovascular Drugs
      • Neurology Drugs
      • Analgesics
      • Adjuvants
      • Others
    • By Material Type:
      • Glass
      • Plastic & Polymer
    • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Drug Class:
      • Cardiovascular Drugs
      • Neurology Drugs
      • Analgesics
      • Adjuvants
      • Others
    • By Material Type:
      • Glass
      • Plastic & Polymer
    • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Drug Class:
      • Cardiovascular Drugs
      • Neurology Drugs
      • Analgesics
      • Adjuvants
      • Others
    • By Material Type:
      • Glass
      • Plastic & Polymer
    • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Sanofi *
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Viatris Inc. (Mylan N.V.)
  • AstraZeneca Plc
  • F. Hoffmann-La Roche AG (Genentech, Inc.)
  • Sun Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Fresenius Kabi AG
  • McKesson Corporation.

 “*” marked represents similar segmentation in other categories in the respective section.